Quarterly report pursuant to Section 13 or 15(d)

Common Stock Warrant Liabilities

v3.24.1.1.u2
Common Stock Warrant Liabilities
3 Months Ended
Mar. 31, 2024
Common Stock Warrant Liabilities  
Common Stock Warrant Liabilities

Note 7 – Common Stock Warrant Liabilities

On December 16, 2022, the Company closed on an offering for the sale of shares of its common stock and pre-funded warrants as part of a registered direct offering. The common stock and the pre-funded warrants were sold together with Series A and Series B common stock warrants. The Company also issued the placement agent warrants to purchase shares of common stock as part of the offering. After the October 2023 Inducement, only the placement agent warrants remained outstanding from this offering.

The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in ASC 480, Distinguishing Liabilities from Equity and ASC 815-40, Derivatives and Hedging - Contracts in Entity’s Own Equity. For warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional paid-in capital at the time of issuance. For warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter.

The Company deemed the placement agent warrants issued in December 2022 to be classified as liabilities on the balance sheet as they contain terms for redemption of the underlying security that are outside its control. The warrants were recorded at the time of closing at a fair value, determined by using the Black-Scholes Model, and will be revalued at each reporting period thereafter for as long as they remain outstanding. The Company revalued the warrants at March 31, 2024 and December 31, 2023, resulting in a fair value of approximately $125,000 for each period.

Common Stock

Warrant

    

Liabilities

Common Stock Warrant liabilities at December 31, 2023

    

$

125

Change in fair value of Common Stock Warrant liabilities

Common Stock Warrant liabilities at March 31, 2024

$

125

The Company used the Black-Scholes Model for determining the estimated fair value of the common stock warrant liabilities. A summary of the weighted average (in aggregate) significant unobservable inputs used in measuring the warrant liability is determined using Level 3 inputs as follows:

    

March 31,

    

December 31,

 

2024

2023

 

Exercise price

$

5.41

$

5.41

Volatility

 

107.5

%  

 

96.4

%

Expected life

 

3.7

 

4.0

Risk-free rate

 

4.2

%  

 

3.8

%

Dividend yield